Reuters logo
BRIEF-Biogen presents data from Phase 1b study of investigational Alzheimer's Disease Treatment at 2016 clinical trials on Alzheimer's Disease Meeting
December 8, 2016 / 11:30 PM / 10 months ago

BRIEF-Biogen presents data from Phase 1b study of investigational Alzheimer's Disease Treatment at 2016 clinical trials on Alzheimer's Disease Meeting

Dec 8 (Reuters) - Biogen Inc

* Biogen presents data from Phase 1b study of investigational Alzheimer’s disease treatment Aducanumab at 2016 clinical trials on Alzheimer’s Disease Meeting

* Aducanumab data presented at CTAD are consistent with previously reported analyses from this study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below